Flexion Therapeutics Inc (FLXN) Return on Investment ROI from the third quarter of 2021 to third quarter of 2020 and for the year 2021, average high and low, overall ranking from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Flexion Therapeutics Inc   (NASDAQ: FLXN)


Flexion Therapeutics Inc's ROI from its third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Flexion Therapeutics Inc's ROI in the third quarter of 2021?
Flexion Therapeutics Inc recorded a cumulative net loss of $-101 million during 12 months ending in the third quarter of 2021, resulting in a negative return on investment (ROI) of -56.5%.

Within the Healthcare sector 705 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2021 quarter, so far to 4381, from total ROI ranking in the second quarter of 2021 at 4511.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Investment Change TTM -10.54 % -5 % 7.05 % -0.77 % -11.08 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 174 170 172 197 212
Return On Investment (TTM) -56.5 % -50.58 % -51.7 % -55.98 % -64.02 %
FLXN's Overall Ranking # 4381 # 4511 # 4371 # 4584 # 4148
Seq. Investment Change TTM -5.13 % -7.88 % 0.43 % 1.92 % 0.75 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -101 -95 -105 -114 -128

FLXN Company Profile >> Back to FLXN Roi Comparisons >> See Annual FLXN Return On Investment



Return On Investment FLXN's Ranking
Within: No.
Industry # 327
Sector # 706
Overall # 4381

Return On Investment Statistics
High Average Low
-0.04 %
-44.52 %
-76.11 %
  (Mar 31 2020)







Financial Statements
Flexion Therapeutics Inc's III. Quarter Investments $ 174 Millions FLXN's Balance sheet
Flexion Therapeutics Inc's III. Quarter Income $ -30 Millions Quarterly FLXN's Income Statement
FLXN's Income by Division See FLXN's Income by Division


FLXN Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 197 181 259 411 209
Y / Y Investment Growth 8.45 % -30.02 % -36.91 % 96.79 % 75.28 %
Net Income in Millions -114 -150 -170 -137 -72
Y / Y Net Income Growth - - - - -
Annual Return On Investment -57.82 % -82.59 % -65.47 % -33.47 % -34.44 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FLXN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FLXN's Competitors
Subscribers only: Roi for Flexion Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for FLXN's Customers

Other Ratios
FLXN's Roa FLXN's Inventory Turnover Ratio FLXN's Growth Rates FLXN's Dividend Statistics
FLXN's Profitability Ratios FLXN's Asset Turnover Ratio FLXN's Dividend Growth
FLXN's Roe FLXN's Valuation Ratios FLXN's Financial Strength Ratios FLXN's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2021, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.